ImmunityBio, Inc. financial data

Symbol
IBRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3530 John Hopkins Court, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
NantKwest, Inc. (to 3/8/2021), Conkwest, Inc. (to 7/13/2015), ZelleRx Corp (to 10/9/2009)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339 % +553%
Debt-to-equity -161 % +6.99%
Return On Equity 63.1 % -41.2%
Return On Assets -104 % +30%
Operating Margin -115K % -82.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 853M shares +26.6%
Common Stock, Shares, Outstanding 853M shares +27.1%
Entity Public Float 980M USD +210%
Common Stock, Value, Issued 85K USD +26.9%
Weighted Average Number of Shares Outstanding, Basic 697M shares +37.1%
Weighted Average Number of Shares Outstanding, Diluted 700M shares +37.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 302K USD -48.5%
Revenue from Contract with Customer, Excluding Assessed Tax 6.11M USD +7346%
Research and Development Expense 190M USD -18.2%
Operating Income (Loss) -344M USD +4.99%
Nonoperating Income (Expense) -69.5M USD +68.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -414M USD +29.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -414M USD +29.1%
Earnings Per Share, Basic -0.59 USD/shares +48.7%
Earnings Per Share, Diluted -0.62 USD/shares +46.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 143M USD -46%
Marketable Securities, Current 6.38M USD +532%
Accounts Receivable, after Allowance for Credit Loss, Current 2.36M USD
Inventory, Net 8.27M USD
Other Assets, Current 1.12M USD -27.4%
Assets, Current 185M USD -37.2%
Property, Plant and Equipment, Net 137M USD -6.15%
Operating Lease, Right-of-Use Asset 33.4M USD -8.7%
Intangible Assets, Net (Excluding Goodwill) 16.1M USD -15.4%
Goodwill 910K USD
Other Assets, Noncurrent 4.83M USD +67.6%
Assets 383M USD -24.1%
Accounts Payable, Current 33.6M USD +241%
Accrued Liabilities, Current 40.6M USD -4.98%
Liabilities, Current 54.9M USD -5.73%
Operating Lease, Liability, Noncurrent 34.8M USD -12.8%
Other Liabilities, Noncurrent 639K USD -42.4%
Liabilities 871M USD -20.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.2M USD +11880%
Retained Earnings (Accumulated Deficit) -3.38B USD -14%
Stockholders' Equity Attributable to Parent -489M USD +16.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -488M USD +16.7%
Liabilities and Equity 383M USD -24.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -107M USD -26.9%
Net Cash Provided by (Used in) Financing Activities 10.2M USD -86.7%
Net Cash Provided by (Used in) Investing Activities -35.6M USD -320%
Common Stock, Shares Authorized 1.35B shares 0%
Common Stock, Shares, Issued 853M shares +27.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -132M USD -719%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.9M USD +54.1%
Deferred Tax Assets, Valuation Allowance 777M USD +19.8%
Deferred Tax Assets, Gross 795M USD +16.5%
Operating Lease, Liability 42.3M USD -6.41%
Depreciation 15.5M USD -6.06%
Payments to Acquire Property, Plant, and Equipment 1.26M USD -85%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -412M USD +29.3%
Lessee, Operating Lease, Liability, to be Paid 55.6M USD -11.7%
Property, Plant and Equipment, Gross 237M USD +2.7%
Operating Lease, Liability, Current 7.47M USD +42.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.73M USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.6M USD +11.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -9.17%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.2M USD -22.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.98M USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 475M USD +12.9%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 34.5M USD -2.61%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.25M USD +12.5%
Operating Lease, Payments 2.38M USD -25%
Amortization of Intangible Assets 2M USD 0%
Depreciation, Depletion and Amortization 4.56M USD -2.69%
Share-based Payment Arrangement, Expense 34.4M USD -30%
Interest Expense 115M USD -11.1%